✦ LIBER ✦

Neuroleptic-induced catalepsy as a model of Parkinson's disease II. Effect of glutamate antagonists

✍ Scribed by P. J. Elliott; S. P. Close; D. M. Walsh; A. G. Hayes; A. S. Marriott

Publisher: Springer
Year: 1990
Tongue: English
Weight: 670 KB
Volume: 2
Category: Article
ISSN: 1435-1463
DOI: 10.1007/bf02260897

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neuroleptic-induced catalepsy as a model

Neuroleptic-induced catalepsy as a model of Parkinson's disease I. Effect of dopaminergic agents

✍ P. J. Elliott; S. P. Close; D. M. Walsh; A. G. Hayes; A. S. Marriott 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 671 KB

Antiparkinsonian effects of remacemide h

Antiparkinsonian effects of remacemide hydrochloride, a glutamate antagonist, in rodent and primate models of Parkinson's disease

✍ Dr. J. Timothy Greenamyre; Robert V. Eller; Zhiming Zhang; Aliza Ovadia; Roger K 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 731 KB

Effects of classical and novel agents in

Effects of classical and novel agents in a MPTP-induced reversible model of Parkinson's disease

✍ S. P. Close; P. J. Elliott; A. G. Hayes; A. S. Marriott 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 622 KB

Adenosine A2A Receptor Antagonists: New

Adenosine A2A Receptor Antagonists: New 8-Substituted 9-Ethyladenines as Tools for in vivo Rat Models of Parkinson's Disease

✍ Rosaria Volpini; Diego Dal Ben; Catia Lambertucci; Gabriella Marucci; Ram Chandr 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 517 KB

Fipamezole (JP-1730) is a potent α2 adre

Fipamezole (JP-1730) is a potent α2 adrenergic receptor antagonist that reduces levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease

✍ Juha-Matti Savola; Michael Hill; Mia Engstrom; Hannele Merivuori; Siegfried Wurs 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

Previous studies in the MPTP-lesioned primate model of Parkinson's disease have demonstrated that alpha(2) adrenergic receptor antagonists such as idazoxan, rauwolscine, and yohimbine can alleviate L-dopa-induced dyskinesia and, in the case of idazoxan, enhance the duration of anti-parkinsonian acti

Protective effects of agmatine in roteno

Protective effects of agmatine in rotenone-induced damage of human SH-SY5Y neuroblastoma cells: Fourier transform infrared spectroscopy analysis in a model of Parkinson’s disease

✍ Salvatore Condello; Emanuele Calabrò; Daniela Caccamo; Monica Currò; Nadia Ferla 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 347 KB